000 01242 a2200325 4500
005 20250515143312.0
264 0 _c20090127
008 200901s 0 0 eng d
022 _a1540-1405
024 7 _a10.6004/jnccn.2008.0063
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aJuergens, Rosalyn A
245 0 0 _aCombined modality therapy of esophageal cancer.
_h[electronic resource]
260 _bJournal of the National Comprehensive Cancer Network : JNCCN
_cOct 2008
300 _a851-60; quiz 861 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAdenocarcinoma
_xtherapy
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xtherapeutic use
650 0 4 _aCarcinoma, Squamous Cell
_xtherapy
650 0 4 _aCombined Modality Therapy
650 0 4 _aEsophageal Neoplasms
_xmortality
650 0 4 _aHumans
650 0 4 _aNeoadjuvant Therapy
650 0 4 _aNeoplasm Staging
650 0 4 _aSurvival Analysis
650 0 4 _aTreatment Outcome
700 1 _aForastiere, Arlene
773 0 _tJournal of the National Comprehensive Cancer Network : JNCCN
_gvol. 6
_gno. 9
_gp. 851-60; quiz 861
856 4 0 _uhttps://doi.org/10.6004/jnccn.2008.0063
_zAvailable from publisher's website
999 _c18389680
_d18389680